As reported by ChainCatcher, Sharps Technology (STSS), a NASDAQ-listed medical device distribution platform and SOL treasury company, disclosed in its Q3 2025 financial report that it earned approximately $17.7 million from staking rewards and digital asset fair value gains. The company raised a total of $411 million through a PIPE financing, with $267 million in cash and stablecoins and $144 million in SOL tokens. As of October 31, 2025, STSS’s treasury held over 2 million SOL tokens. The company has fully exited traditional syringe manufacturing and now focuses on medical device distribution and maximizing the value of its SOL treasury.
Sharps Technology Q3 Earns $17.7M from Staking and Digital Asset Gains
ChaincatcherShare
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.